Skip to main content

IDT, Roche 454 Ink Deal for Custom Primers

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Integrated DNA Technologies today announced the signing of an exclusive agreement with Roche 454 Life Sciences for the provision of custom primers for 454's GS FLX Titanium Chemistry for use on the GS FLX System and the GS Junior System.

The products are available as FusionPrimers or Rapid Library MID — molecular identification — adaptor oligos, and are used for amplicon or shotgun sequencing, IDT said in a statement. Its unique design software allows researchers to create specific primers to target individual or multiple exons from one or more genes, the company added.

According to IDT, the GS FLX Titanium FusionPrimers have a 25 base pair fixed sequence at the 5' end and enable the sequencing of longer amplicons and increased reads per run. The optional MID sequence acts as a barcode and allows libraries to be multiplexed for subsequent identification.

The GS FLX Titanium RapidLibrary MID Adaptor Oligos are for shotgun sequencing and incorporate MIDs as standard. The adaptors are "especially useful" for sequencing numerous small samples in parallel, lowering the cost of sequencing per sample, IDT said.
Financial terms of the deal were not disclosed.

Two years ago, IDT signed a deal to provide Roche Diagnostics with fusion primers for some 454 sequencing applications.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.